These results point toward an immunoregulatory role of nigericin-induced pathways such as NLRP3 activation in tumor immunology, supporting our own data on a role for IL-18 in limiting effector function of T cells under specific conditions of intratumoral antigen recognition [19]. Here, NLRP3 is linked to neoplasm.